These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10216097)

  • 1. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.
    Zeng W; Nakao S; Takamatsu H; Yachie A; Takami A; Kondo Y; Sugimori N; Yamazaki H; Miura Y; Shiobara S; Matsuda T
    Blood; 1999 May; 93(9):3008-16. PubMed ID: 10216097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens.
    Kook H; Risitano AM; Zeng W; Wlodarski M; Lottemann C; Nakamura R; Barrett J; Young NS; Maciejewski JP
    Blood; 2002 May; 99(10):3668-75. PubMed ID: 11986222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe aplastic anemia with autoimmune thyroiditis showing no hematological response to intensive immunosuppressive therapy.
    Tomonari A; Tojo A; Iseki T; Ooi J; Hase H; Shirafuji N; Tani K; Asano S
    Acta Haematol; 2003; 109(2):90-4. PubMed ID: 12624493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanism of aplastic anemia.
    Nakao S
    Int J Hematol; 1997 Aug; 66(2):127-34. PubMed ID: 9277043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia.
    Piao W; Grosse J; Czwalinna A; Ivanyi P; Ganser A; Franzke A
    Exp Hematol; 2005 Jul; 33(7):804-10. PubMed ID: 15963856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
    Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
    Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia.
    Manz CY; Dietrich PY; Schnuriger V; Nissen C; Wodnar-Filipowicz A
    Blood Cells Mol Dis; 1997; 23(1):110-22. PubMed ID: 9215756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry.
    Risitano AM; Kook H; Zeng W; Chen G; Young NS; Maciejewski JP
    Blood; 2002 Jul; 100(1):178-83. PubMed ID: 12070025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
    Plasilova M; Risitano A; Maciejewski JP
    Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia.
    Nakao S; Takamatsu H; Chuhjo T; Ueda M; Shiobara S; Matsuda T; Kaneshige T; Mizoguchi H
    Blood; 1994 Dec; 84(12):4257-61. PubMed ID: 7994040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.
    Zhu F; Qiao J; Zhong XM; Wu QY; Chen W; Yao Y; Niu MS; Fu CL; Zeng LY; Li ZY; Xu KL
    Med Oncol; 2015 Jul; 32(7):197. PubMed ID: 26049920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep sequencing and flow cytometric characterization of expanded effector memory CD8
    Giudice V; Feng X; Lin Z; Hu W; Zhang F; Qiao W; Ibanez MDPF; Rios O; Young NS
    Haematologica; 2018 May; 103(5):759-769. PubMed ID: 29419434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: two case reports.
    Sugimori C; Kaito K; Nakao S
    Int J Hematol; 2003 May; 77(4):391-4. PubMed ID: 12774930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
    Risitano AM
    Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia.
    Ren J; Hou XY; Ma SH; Zhang FK; Zhen JH; Sun L; Sun YX; Hao YL; Cheng YF; Hou M; Xu CG; Zhang MH; Peng J
    J Intern Med; 2014 Nov; 276(5):512-24. PubMed ID: 24528288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
    Chandra J; Naithani R; Ravi R; Singh V; Narayan S; Sharma S; Pemde H; Dutta AK
    Indian J Pediatr; 2008 Mar; 75(3):229-33. PubMed ID: 18376089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
    Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia.
    Nakao S; Yamaguchi M; Shiobara S; Yokoi T; Miyawaki T; Taniguchi T; Matsuda T
    Blood; 1992 May; 79(10):2532-5. PubMed ID: 1586705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.